Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Obsidian Therapeutics, Inc. before investing.

In this article, we go over a few key elements for understanding Obsidian Therapeutics, Inc.’s stock price such as:

• Obsidian Therapeutics, Inc.’s current stock price and volume
• Why Obsidian Therapeutics, Inc.’s stock price changed recently
• Upgrades and downgrades for OBX from analysts
• OBX’s stock price momentum as measured by its relative strength

About Obsidian Therapeutics, Inc. (OBX)

Before we jump into Obsidian Therapeutics, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies. The company is developing investigational therapies, including OBX-115, which is being evaluated in clinical trials for advanced solid tumors, advanced melanoma, and relapsed refractory non-small cell lung cancer. It utilizes a proprietary Cytodriver technology platform designed to regulate protein function using FDA-approved small-molecule drugs and is advancing tumor-infiltrating lymphocyte (TIL) cell therapies that leverage mbIL15 to enhance persistence, antitumor activity, and clinical safety. Access to investigational therapies is currently limited to participation in clinical trials, and the company collaborates with other organizations to apply its platform technology. The company was founded in 2015 and is based in Cambridge, Massachusetts.

Want to learn more about Obsidian Therapeutics, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Obsidian Therapeutics, Inc..

Obsidian Therapeutics, Inc.’s Stock Price as of Market Close

As of October 23, 2026, 4:00 PM, CST, Obsidian Therapeutics, Inc.’s stock price was $13.980.

Obsidian Therapeutics, Inc. is up 0.29% from its previous closing price of $13.940.

During the last market session, Obsidian Therapeutics, Inc.’s stock traded between $13.430 and $14.170. Currently, there are approximately 21.81 million shares outstanding for Obsidian Therapeutics, Inc..

Obsidian Therapeutics, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Obsidian Therapeutics, Inc. Stock Price History

Obsidian Therapeutics, Inc.’s (OBX) price is currently up 1.82% so far this month.

During the month of October, Obsidian Therapeutics, Inc.’s stock price has reached a high of $14.680 and a low of $11.520.

Over the last year, Obsidian Therapeutics, Inc. has hit prices as high as $49.970 and as low as $11.520.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Obsidian Therapeutics, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of October 23, 2026, there were analysts who downgraded Obsidian Therapeutics, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Obsidian Therapeutics, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Obsidian Therapeutics, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Obsidian Therapeutics, Inc. (OBX) by visiting AAII Stock Evaluator.

Relative Price Strength of Obsidian Therapeutics, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of October 23, 2026, Obsidian Therapeutics, Inc. has a weighted four-quarter relative price strength of %, which translates to a Momentum Score of and is considered to be NA.

Want to learn more about how Obsidian Therapeutics, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Obsidian Therapeutics, Inc. Stock Price: Bottom Line

As of October 23, 2026, Obsidian Therapeutics, Inc.’s stock price is $13.980, which is up 0.29% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Obsidian Therapeutics, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.